4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-060538
EVP, Research & CSO sold 2,340 shares at $27.29 ($63,848)
- EVP, Research & CSO acquired 2,340 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Virgin Herbert · EVP, Research & CSO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-11-24 | Exercise or conversion : show line 1 in the form | +2,340 | $1.53 | $3,580 | 26,040 | D |
| 2020-11-24 | Sale : show line 2 in the form | −2,340 | $27.29 | $63,848 | 23,700 | D |
| Open-market sales · 2,340 sh · avg $27.29 · $63,848 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-11-24 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −2,340 | 445,830 | D |
Loading xslF345X03/doc4.xml…